ABSTRACT Several clinical studies suggest the involvement of premature ageing processes in chronic obstructive pulmonary disease (COPD). Using an epidemiological approach, we studied whether accelerated ageing indicated by telomere length, a marker of biological age, is associated with COPD and asthma, and whether intrinsic age-related processes contribute to the interindividual variability of lung function.
Introduction
An increasing life expectancy is associated with an increased susceptibility for prevailing chronic diseases, such as cardiovascular and neurological diseases, type 2 diabetes and cancer, suggesting that common, agerelated processes are involved in these diseases [1] [2] [3] [4] . The lung is known to undergo age-related processes associated with a continuous decline in lung function [5, 6] . Chronic obstructive pulmonary disease (COPD), lung cancer and idiopathic pulmonary fibrosis are lung diseases with an increase in incidence by age. In COPD, chronic inflammation and oxidative stress are among the generally accepted pathophysiological mechanisms but, as discussed for other degenerative diseases, accelerated ageing resulting in premature cell senescence may contribute to the pathobiology [7] [8] [9] . Although clinical and epidemiological studies provide some evidence for this hypothesis, the data base is still limited [8] , so our study aimed to provide further clues on this.
Telomeres, made up of the simple repetitive sequence TTAGGG in humans [10] , are specialised DNA structures that, in concert with telomere-specific proteins, protect the ends of chromosomes and maintain the integrity of the genome [3] . They progressively shorten with each cell division [11] and, after reaching a critical length, either cellular senescence or apoptosis is induced [3] . Telomeres are therefore considered a marker of biological age. Their length is affected by various factors, such as chronic inflammation or oxidative stress [3] , but has also been shown to have a heritable component [12] . Recent data suggest that shorter telomere length is associated with an increased risk of total and cancer mortality in COPD patients [13] . Shortened telomeres were found in pulmonary vascular endothelial cells, alveolar epithelial cells and circulating leukocytes of COPD patients [14] [15] [16] [17] [18] , supporting the notion of accelerated ageing in COPD. RODE et al. [18] reported multivariable-adjusted odds ratios of 1.15 (95% CI 1.06-1.25) for shortest versus longest telomere quartiles for COPD. Smoking, a major cause of COPD, is associated with different signs of premature ageing, which is particularly obvious in the skin [8] , suggesting that environmental exposure may play an important role in triggering processes related to biological ageing.
Since the lung is continuously exposed to environmental hazards, lung function per se may be a surrogate marker for biological age in light of the large interindividual variability observed [19] . Only a few casecontrol studies [14, 20] have investigated the relationship between telomere length and spirometric indices. One large population-based study was recently published by RODE et al. [18] reporting a modest correlation between telomere length and lung function in terms of the spirometric indices forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and their ratio, FEV1/FVC.
In a meta-analysis of 14 European studies embedded in the ENGAGE (European Network for Genetic and Genomic Epidemiology) consortium, we studied the relationship between telomere length, lung function and lung disease to address the question of whether accelerated ageing, indicated by telomere length, may be involved in the pathogenesis of COPD and asthma, and whether intrinsic age-related processes may contribute to the interindividual variability of lung function. For this purpose, we explored the association between circulating leukocyte telomere length and COPD or asthma. Although these are different obstructive disease entities, they share chronic inflammation as a hallmark of disease, which may result in accelerated ageing and telomere shortening. We further investigated the association between telomere length and lung function using the spirometric indices FEV1, FVC and FEV1/FVC.
Methods

Study populations
This meta-analysis comprises data from 14 European studies, with details provided in the online supplementary material. In the analysis of telomere length and COPD, we combined data of nine studies (EX-ATHLETES, [22, 23] . Relative telomere length was determined by quantitative PCR [24] in all studies. Measurement details by study are provided in the online supplementary data. Local ethics committees approved all studies and all participants had given their written informed consent. 
Statistical analysis
Associations of telomere length with COPD, asthma, FEV1, FVC and FEV1/FVC were tested by linear regression models with telomere length as the outcome in all models. To account for heterogeneity between studies, telomere length was standardised within each study prior to the analysis, using a z-transformation after initially adjusting for age and sex, i.e. scaling the residuals of the regression of telomere length on age and sex to zero mean and unit variance. COPD and asthma cases were coded ''1'', whereas controls were coded ''0''. In addition, the spirometric indices were transformed to z-scores taking into account the age, height and sex of each individual. Therefore, GLI reference equations for spirometry [19] were applied to calculate z-scores for FEV1, FVC and FEV1/FVC from skewness (L), the coefficient of variation (S) and the predicted value (M) according to the LMS equations by using the software provided at www.lungfunction.org/tools
Within the linear regression model, we adjusted for ever and current smoking, as well as for study-specific covariates such as case/control status or family structure if appropriate. As both telomere length and lung function measurements were already adjusted for age and sex, the association model itself did not contain these covariates. All analyses were primarily conducted in all available study samples and additionally conducted stratified by sex. The z-transformation of telomere length was performed in males and females separately for the sex-stratified analysis. For the analyses of FEV1, FVC and FEV1/FVC, we additionally stratified into the subgroups ''apparently lung healthy'', ''COPD cases'' and ''asthmatics''.
The group of apparently lung-healthy subjects was determined by exclusion of all subjects with a history of asthma, COPD or other reported respiratory diseases, and all subjects with a reported acute respiratory tract infections within the last 3 weeks. The group was further divided into ''current/former'' and ''never'' smokers. In the group of healthy smokers, we further investigated subjects showing the lower and upper 25% quantiles of lung function (FEV1, FVC or FEV1/FVC). The single-study results were combined in a meta-analysis with inverse variance weighting, performed in the statistical software R (www.r-project.org) using the meta-package with fixed and random effects. As a measure of heterogeneity, inconsistency (I 2 ) values were calculated [25] and Cochran's heterogeneity test was performed. As a sensitivity analysis in COPD, we excluded first all subjects .70 years of age and then all subjects .60 years of age from the analysis.
Results
COPD
By combining nine studies including 934 COPD cases and 15 846 controls according to the GLI criteria (table 1) , we observed a significant negative association between COPD and telomere length (b5 -0.0982, p50.001 with fixed effects; b5 -0.0953, p50.012 with random effects, I
2 527.7%, p-value for heterogeneity (phet)50.198). With COPD defined by the GOLD criteria, there were more COPD cases (n51189) with an increase in older and a reduction in younger individuals. On the other hand, the association with telomere length using GOLD criteria was more heterogeneous across studies and less significant (b5 -0.0676, p50.018 with fixed effects; b5 -0.0629, p50.117 with random effects; I 2 542.3%, phet50.085). Figure 1 shows study-specific and combined effect estimates of a fixed-and random-effects model with COPD defined by the GLI criteria. The association was strong in the female subsample (n510 435; b5 -0.1306, p53.6610 -4 with fixed effects; b5 -0.1312, p56.7610 -4 with random effects; I 2 55.8%, phet50.385) whereas in the male subsample, no significant relationship was detectable (n56345; b5 -0.0242, p50.663 with fixed effects; b5 -0.0329, p50.622 with random effects; I 2 523.5%, phet50.250). Online supplementary figure E1 shows the meta-analysis stratified for sex. The two studies showing positive effect estimates, EX-ATHLETES and NAG-FIN, are selective in their study design: NAG-FIN comprises families of heavy eversmokers, and the EX-ATHLETES are male former elite athletes and matched controls with a mean age of 72.7 years. Since COPD shows an age-related increase in incidence, we conducted sensitivity analyses to investigate whether the observed association is affected by age. Exclusion of subjects .70 or .60 years of age showed no significant differences for the effect estimates in subgroups of both sexes ( fig. E2) , confirming that the association is not driven by older age groups.
Asthma
By combining 13 studies with 2834 asthma cases and 28 195 controls (table 2 and fig. 2 ), we observed a negative association between telomere length and asthma. This was significant in a fixed-effects model (b5 -0.0452, p50.024) and suggestive in a random-effects model (b5 -0.0446, p50.093; I 2 530.4%, phet50.140). The effect was driven by the female subsample (n518 724, b5 -0.0764, p50.002 with fixed effects; b 5 -0.0809, p50.005 with random effects; I 2 515.8%, phet50.289) and not seen in the male subsample (n512 305; b50.0182, p50.594 with fixed effects; b50.0139, p50.771 with random effects; I 2 540.3%, phet50.080; fig. E3 ).
Lung function
By combining the data of seven studies, totalling 12 595 individuals (table 3 and fig. 3 ), we observed highly significant positive associations between telomere length and spirometric indices measured as FEV1 (b50.0455, p51.07610 -7 with fixed and random effects; I 2 50%), FVC (b50.0401, p52.07610 -5 with fixed and random effects; I 2 50%) and FEV1/FVC (b50.0238, p55.27610 -3 with fixed and random effects; I 2 50%). The effect for FEV1 was higher in females than in males (b50.0548 versus b50.286 with random effects). The meta-analysis stratified by sex is shown in figure E4 . Figure 4 shows the association results stratified by lung health status. Compared with ''healthy'' controls, we found somewhat stronger effects in the disease subgroups of COPD and asthma cases. Comparisons of the effect estimates stratified by health status and by sex are presented in figure E5 . The stronger effects found in COPD were predominantly seen in males and were less obvious in females. The opposite was observed for asthma, where the effects were strong in females. With regard to smoking, within the healthy subgroups, the observed effects were stronger in ''healthy never-smokers'' than in ''healthy ever-smokers'' for FEV1 and FVC ( fig. E6 ). To further explore the contribution of smoking, we stratified the group of healthy smokers (current or ex-smokers) by lung function status (lower 25% or upper 25% within this subgroup). The results suggest that there was no difference between those two groups for FEV1. In FVC, an effect was only seen in individuals with poor lung function (lower 25%). Although differences between subgroups were noticeable, they did not differ significantly.
Discussion
We conducted a large study investigating the relationship between telomere length and lung function and disease, assessed in multiple European cohorts unselected for lung disease. We found highly significant positive associations between telomere length from peripheral leukocytes and spirometric indices measured as FEV1, FVC and FEV1/FVC in a meta-analysis of seven studies with 12 595 individuals. When stratifying by lung health status, larger effects were seen in the subgroups of COPD patients or asthmatics. This suggests that lung function decline, in part, reflects biological ageing due to intrinsic processes, which are likely to be aggravated in asthma or COPD due to mechanisms promoting cell senescence.
Tobacco smoke is a well-known environmental factor that promotes ageing processes and cellular senescence [8] . The recent large, population-based study by RODE et al. [18] revealed that having ever smoked and the cumulative pack-years smoked were associated with telomere length in 46 396 adults. This is in line with previous population-based findings [26] . However, in clinical studies, these effects were not seen [14, 17, 20] . When stratifying by smoking status, we observed no evident associations between telomere length and lung function indices in ever-smokers. In addition, stratifying by lung function within the group of healthy smokers (current and ex-smokers) did not clarify the issue, although for FVC, an effect could be detected in smokers of the lower quartile. The underlying reason for not detecting an effect may be found in the complex interactions between smoking and genetic and/or lifestyle factors, such as dietary antioxidants or physical activity, affecting biological age and its markers [1, 3, [27] [28] [29] [30] [31] [32] , but also in the heterogeneity of smoking exposure, and its amount and duration.
Up to now, a limited number of studies have addressed the association between lung function and telomere length. MUI et al. [20] observed a positive association in a sample of COPD patients and TSUJI et al. [16] reported that airflow limitation and alveolar cell senescence were positively correlated with each other.
Other studies failed to find significant associations between spirometric parameters and telomere length [14, 17, 33] , although one study found that parameters of gas exchange (arterial oxygen and carbon dioxide pressures) were associated with telomere length in COPD patients [14] . The large population-based study by RODE et al. [18] found weak but statistically significant positive correlations between telomere length and spirometric indices, which is confirmed by our results. Furthermore, we observed the effects to be somewhat stronger in COPD or asthma patients compared with healthy individuals, suggesting that intrinsic agerelated processes may be aggravated by chronic inflammatory processes occurring either locally in the lung or systemically.
In both COPD and asthma patients, we observed shorter telomeres compared with healthy controls. In COPD, the association was stronger when defining cases by the age-dependent LLN for FEV1/FVC according to the GLI criteria [19] compared with the fixed cut-off given by GOLD [21] . This suggests that the GLI approach better suits the transition from health to disease. For COPD and asthma, effect estimates appeared to be larger in females than in males, although sex differences were not statistically significant. With respect to COPD, this might be consistent with the observation that females appear to be more susceptible to COPD than males [34] but the causality certainly needs to be proved. Whereas our findings for asthma are novel, the results for COPD are in line with previous findings in case-control [14] [15] [16] [17] and population-based studies [18] . This suggests that, as already shown for other chronic diseases [1, 3, 35] , accelerated ageing may contribute to the pathogenesis of asthma and COPD.
Our epidemiological finding is supported by results from clinical studies showing shorter telomeres in alveolar epithelial and endothelial cells from patients with emphysema [16] . AMSELLEM et al. [15] reported a higher percentage of pulmonary vascular endothelial cells stained for senescence markers in COPD patients than in lung healthy controls. This is in line with senescent-type growth characteristics of lung fibroblasts [36] . Furthermore, cellular senescence of pulmonary smooth muscle cells appears to be involved in the pathogenesis of pulmonary hypertension in COPD [37] . Several mechanisms have been proposed for abnormal ageing in COPD, including chronic inflammation, oxidative stress, mitochondrial dysfunction, altered energy metabolism, abnormal regulation of ageing processes, cellular and immunosenescence, and telomere dysfunction [3, [7] [8] [9] 15] . Analogous mechanisms in asthma have not been explored in detail but, due to the inflammatory nature of both diseases, some of the aforementioned factors are also likely to play a role in asthma. Possible consequences for both diseases are very difficult to predict but one might speculate that the ageing processes may be reflected in shorter life expectancy and an increased risk of cognitive impairment and dementia as reported for asthma and COPD [38] [39] [40] .
The observed associations between telomere length and both diseases were not as strong as one might have initially expected, considering the large sample size. In the case of COPD, in the population-based approach of RODE et al. [18] , a much weaker association was also observed than previous case-control studies had suggested [14] . In our case, this may be related to the fact that mostly mild-to-moderate disease stages were included in the study samples. Moreover, as in many other studies, telomere length was measured in circulating leukocytes and not in the cells of the primarily affected organ, i.e. the lung. Studies addressing the comparability of telomere length between different tissues found strong correlations in healthy individuals, but somewhat blunted ones in disease [41] [42] [43] [44] . We cannot rule out that this may be a factor that affects the association of telomere length with lung diseases. Leukocyte telomere length is a complex trait that is shaped by many factors including genetic, epigenetic, lifestyle and environmental determinants, and their complex interaction is hardly understood. In the present analysis, we therefore adjusted only for well accepted determinants. Certainly, the population-based epidemiological nature of the studies included comes along with distinct limitations. Population-based samples typically only scarcely include severe cases of lung diseases; therefore, early disease stages predominate, in which age-related mechanisms may not be as significant as in more advanced stages that are primarily included in clinical cohorts [14] [15] [16] [17] . Furthermore, our study design did not allow us to take into account the known heterogeneity of COPD and asthma phenotypes. These entities may have different impacts on telomere length or may trigger premature ageing processes via telomere-independent mechanisms, as reported for fibroblasts of patients with lung emphysema [45] . Unlike in clinical studies, diagnosis of COPD and asthma had to rely mainly on self-reported physician diagnosis, which certainly adds some potential for misclassification error. However, we employed the recent GLI reference values [19] for COPD diagnosis wherever possible. In addition, confounding effects, such as smoking or medication, could not be accounted for in the same way as in a matched case-control study design.
As this analysis combines a number of studies that are heterogeneous in their design (online supplementary material), we report results of random-effects models in addition to the results based on fixed effects, in order to account for this heterogeneity. Naturally, confidence intervals are larger with random effects. While both models reach statistical significance in COPD, statistical significance was only reached with the fixedeffects model for asthma. The observed effect point estimates, however, were comparable between the fixedand the random-effects model, supporting the biological significance of our findings. In COPD, our sensitivity analysis did not show an age dependency ( fig. E2 ). Two studies showing positive effect estimates for COPD were selective in their study design; in the case of the EX-ATHLETES study, the positive effect of lifetime physical exercise on biological age may have played a role [3, 27, 46, 47] .
Conclusions
We investigated the relationship of telomere length, as a marker of biological age, with lung function and respiratory disease. We found highly significant positive associations between telomere length and lung function. Furthermore, shorter telomeres were seen in patients with COPD and asthma cases compared with healthy controls. Our results provide indirect evidence for the hypothesis that premature ageing is involved in the pathophysiology of COPD and asthma, and that lung function partially reflects biological ageing due to intrinsic processes. These processes are likely to be aggravated by lung diseases promoting cellular senescence, although the average effect seems to be not particularly strong.
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